Compare VanEck JP Morgan EM Local Currency Bond ETF (EMLC) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck JP Morgan EM Local Currency Bond ETF vs Revvity Inc — how do they compare? VanEck JP Morgan EM Local Currency Bond ETF trades at $25.47, while Revvity Inc trades at $111.75 (market cap $12.42B). The key difference: Revvity Inc pays a 0.25% dividend while VanEck JP Morgan EM Local Currency Bond ETF pays none, and Revvity Inc is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals.
| EMLC | RVTY | |
|---|---|---|
Sector | Fixed Income | Technology |
52-Week High | $26.59 | $117.75 |
52-Week Low | $24.83 | $82.26 |
Market Cap | — | $12.42B |
Enterprise Value | — | $14.91B |
Dividend Yield | — | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMLC trades at $25.47 with minimal daily movement (-0.06%). Technical indicators show a bullish trend with moving averages supporting upward momentum, though oscillators remain neutral. The ETF maintains consistent dividend payments of $0.14 per share quarterly, providing income stability. Recent news highlights growing institutional interest in emerging market debt as investors seek yield above Treasury bonds.
The outlook remains positive given the 6.1% yield advantage over Treasuries, though currency risk and capital erosion concerns persist. Short interest has surged 73% recently, indicating some skepticism about sustainability. Federal Reserve policy decisions will be crucial for EM debt performance through 2026.
RVTY trades at $111.40, up 0.17% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company maintains stable revenue around $2.9B with an 8.26% net income margin, though its P/E ratio of 53.53 suggests premium valuation. Recent news highlights AI integration advances and FDA clearances, supporting growth initiatives.
Outlook is cautiously optimistic with strong analyst buy ratings (51.72%) and a $111.43 consensus target, but high valuation and margin pressures pose risks. Earnings on August 4, 2026, will be critical for confirming growth trajectory amid competitive and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
